RNTX

Rein Therapeutics
RNTX

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $15.7M invested in Rein Therapeutics in 2017 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.16M
2
+$633K
3
+$254K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$233K
5
State Street
State Street
Massachusetts
+$229K

Top Sellers

1
-$8.77M
2
-$1.27M
3
-$1.14M
4
MIM
Monashee Investment Management
Massachusetts
-$836K
5
HCM
Highbridge Capital Management
New York
-$562K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$12K
27
$11K
28
$8K
29
$6K
30
$4K
31
$2K
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
1
2